Compare CYBERDYNE, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 33,262 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.10
-0.64%
0.84
Revenue and Profits:
Net Sales:
963 Million
(Quarterly Results - Sep 2025)
Net Profit:
-180 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
63.24%
0%
63.24%
6 Months
76.61%
0%
76.61%
1 Year
46.6%
0%
46.6%
2 Years
-3.21%
0%
-3.21%
3 Years
-9.31%
0%
-9.31%
4 Years
-46.17%
0%
-46.17%
5 Years
-41.02%
0%
-41.02%
CYBERDYNE, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.59%
EBIT Growth (5y)
-10.10%
EBIT to Interest (avg)
-113.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.10
Tax Ratio
20.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.62
EV to EBIT
-10.96
EV to EBITDA
-17.16
EV to Capital Employed
0.55
EV to Sales
4.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.98%
ROE (Latest)
-1.78%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
963.00
988.00
-2.53%
Operating Profit (PBDIT) excl Other Income
-44.00
-283.00
84.45%
Interest
278.00
169.00
64.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-180.00
-377.00
52.25%
Operating Profit Margin (Excl OI)
-207.70%
-432.20%
22.45%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -2.53% vs -6.62% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 52.25% vs 61.49% in Sep 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
4,384.00
4,354.00
0.69%
Operating Profit (PBDIT) excl Other Income
-904.00
-1,059.00
14.64%
Interest
303.00
482.00
-37.14%
Exceptional Items
314.00
-297.00
205.72%
Consolidate Net Profit
-706.00
-1,648.00
57.16%
Operating Profit Margin (Excl OI)
-341.20%
-398.70%
5.75%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 0.69% vs 32.38% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 57.16% vs -319.34% in Mar 2024
About CYBERDYNE, Inc. 
CYBERDYNE, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






